Psilocybin is poised to be a major player in the world of psychedelic medicines. A number of Phase 2 trials on psilocybin are underway, Phase 3 trials are on the near horizon, and psilocybin is scheduled to be available for medical use in Oregon in under two years!
This may have you wondering just how this component of what the counterculture called ‘magic mushrooms’ may soon be able to do for your patients.
We’ve seen trials using psilocybin to address a number of conditions, from depression to eating disorders to migraines. So how does it work and what does therapy with psilocybin look like?
To answer those questions, we are honored to have four panelists on this month’s webinar to cover:
• The results of a number of studies involving psilocybin
• What psilocybin-assisted psychotherapy is and how it’s done
• The development of Oregon’s legalization model and what this effort and decriminalization efforts across the globe may mean for your patients
As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, July 22nd at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterwards if you cannot make it to the live event.
Hope to see you all on the 22nd!


